Pilot Therapeutics Holdings Inc.
PLTT
$0.0001
$0.000.00%
OTC PK
| 06/30/2003 | 03/31/2003 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.77% | 47.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.71% | 42.26% | |||
| Operating Income | -7.71% | -42.26% | |||
| Income Before Tax | -3.54% | -29.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.54% | -29.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.54% | -29.38% | |||
| EBIT | -7.71% | -42.26% | |||
| EBITDA | -7.72% | -43.41% | |||
| EPS Basic | -3.46% | -29.63% | |||
| Normalized Basic EPS | -3.48% | -31.18% | |||
| EPS Diluted | -3.46% | -29.63% | |||
| Normalized Diluted EPS | -3.48% | -31.18% | |||
| Average Basic Shares Outstanding | 0.07% | -0.21% | |||
| Average Diluted Shares Outstanding | 0.07% | -0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||